Metraipolis › archive › dc_a30b689a032f

Nigeria's post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications — Europe PMC PMID:41810010

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41810010
DOI: 10.4102/jphia.v17i1.1560
License (as archived): solo-consultazione
Archived: 2026-11-06T07:29:18.556Z
SHA-256 of the archived text: 46c9bdee3af069de69170133386b0cb6310114cb1456af5a08a01efe42c732c2
Stable URL of this page: https://metraipolis.com/documento/dc_a30b689a032f

How to cite

Nigeria's post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications — Europe PMC PMID:41810010 — Europe PMC (en), https://europepmc.org/article/MED/41810010 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a30b689a032f (Metraipolis archive dc_a30b689a032f, sha256 46c9bdee3af069de69170133386b0cb6310114cb1456af5a08a01efe42c732c2)

BibTeX

@misc{dca30b689a032f,
  title = {Nigeria's post-COVID-19 vaccine manufacturing ambitions: Opportunities and regional implications — Europe PMC PMID:41810010},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41810010},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a30b689a032f; sha256 46c9bdee3af069de69170133386b0cb6310114cb1456af5a08a01efe42c732c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41810010. Agents can read the archived copy with the MCP tool read_document.